IRONWOOD PHARMACEUTICALS INC Net Cash Provided by (Used in) Financing Activities in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Ironwood Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $6K.
  • Ironwood Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$107M, a 139% decline from 2023.
  • Ironwood Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $277M.
  • Ironwood Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$238M, a 5121% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

IRONWOOD PHARMACEUTICALS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $6K* +$15.6M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q1 2024 -$15.6M -$19.5M -491% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q1 2023 $3.98M +$94.9M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 -$90.9M -$93.1M -4210% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $2.21M -$9.74M -81.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $12M +$20.7M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 -$8.77M -$14.1M -266% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $5.29M -$13.8M -72.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2017 $19.1M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q1 2015 $5.42M -$189M -97.2% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-06
Q1 2014 $194M +$23.7M +13.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q1 2013 $170M +$84.2M +97.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q1 2012 $86.1M Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-23

IRONWOOD PHARMACEUTICALS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$107M -$384M -139% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $277M +$515M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 -$238M -$233M -5121% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-31
2021 -$4.55M -$23.1M -125% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
2020 $18.5M +$19.7M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 -$1.19M -$31.3M -104% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $30.1M +$10.2M +51.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-17
2017 $19.8M +$24M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 -$4.18M -$307M -101% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-25
2015 $303M +$92.1M +43.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $211M -$103M -32.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-22
2013 $314M +$225M +252% Jan 1, 2013 Dec 31, 2013 10-K 2015-02-18
2012 $89M +$85.8M +2740% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-18
2011 $3.13M -$200M -98.5% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-07
2010 $203M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.